| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |